Cargando…

Examining the risk of depression or self-harm associated with incretin-based therapies used to manage hyperglycaemia in patients with type 2 diabetes: a cohort study using the UK Clinical Practice Research Datalink

OBJECTIVES: To compare population-based incidence rates of new-onset depression or self-harm in patients initiating incretin-based therapies with that of sulfonylureas (SU) and other glucose-lowering agents. DESIGN: Population-based cohort study. SETTING: Patients attending primary care practices re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gamble, John-Michael, Chibrikov, Eugene, Midodzi, William K, Twells, Laurie K, Majumdar, Sumit R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Diabetes and Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194463/ https://www.ncbi.nlm.nih.gov/pubmed/30297350 http://dx.doi.org/10.1136/bmjopen-2018-023830

Ejemplares similares

Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute Outcomes
por: Gamble, John-Michael, et al.
Publicado: (2018)

Comparative effectiveness of incretin-based therapies and the risk of death and cardiovascular events in 38,233 metformin monotherapy users
por: Gamble, John-Michael, et al.
Publicado: (2016)

Characterising the burden of chronic kidney disease among people with type 2 diabetes in England: a cohort study using the Clinical Practice Research Datalink
por: Cook, Sarah, et al.
Publicado: (2023)

Prediction of type 2 diabetes risk in people with non-diabetic hyperglycaemia: model derivation and validation using UK primary care data
por: Coles, Briana, et al.
Publicado: (2020)

Population trends in the 10-year incidence and prevalence of diabetic retinopathy in the UK: a cohort study in the Clinical Practice Research Datalink 2004–2014
por: Mathur, Rohini, et al.
Publicado: (2017)

Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: a systematic review and meta-analysis
por: Donnan, Jennifer R, et al.
Publicado: (2019)

Outcomes of hyperglycaemia in pregnancy in Africa: systematic review study protocol
por: Musa, Ezekiel, et al.
Publicado: (2021)

Cohort profile for the MASTERMIND study: using the Clinical Practice Research Datalink (CPRD) to investigate stratification of response to treatment in patients with type 2 diabetes
por: Rodgers, Lauren R, et al.
Publicado: (2017)

Diabetes and intermediate hyperglycaemia in Kisantu, DR Congo: a cross-sectional prevalence study
por: Muyer, Muel Telo, et al.
Publicado: (2012)

Changing use of antidiabetic drugs in the UK: trends in prescribing 2000–2017
por: Wilkinson, Samantha, et al.
Publicado: (2018)

Effect of hyperglycaemia in pregnancy on adiposity in their infants in India: a protocol of a multicentre cohort study
por: Babu, Giridhara R, et al.
Publicado: (2014)

Effects of Incretin Pathway Elements on Bone Properties
por: Abdi, Arezoo M, et al.
Publicado: (2023)

Association between serum soluble corin and hyperglycaemia: a cross-sectional study among Chinese adults
por: Liu, Yan, et al.
Publicado: (2015)

Management of hyperglycaemia in persons with non-insulin-dependent type 2 diabetes mellitus who are started on systemic glucocorticoid therapy: a systematic review
por: Tatalovic, Milos, et al.
Publicado: (2019)

Study protocol of the randomised placebo-controlled GLOBE trial: GLP-1 for bridging of hyperglycaemia during cardiac surgery
por: Hulst, Abraham H, et al.
Publicado: (2018)

A cross-sectional study of glucose regulation in young adults with very low birth weight: impact of male gender on hyperglycaemia
por: Sato, Ryosuke, et al.
Publicado: (2012)

Personalising activity to target peak hyperglycaemia and improve cardiometabolic health in people with type 2 diabetes: protocol for a randomised controlled trial
por: Chang, Courtney R, et al.
Publicado: (2022)

Ability of verbal autopsy data to detect deaths due to uncontrolled hyperglycaemia: testing existing methods and development and validation of a novel weighted score
por: Blackstock, Sarah, et al.
Publicado: (2019)

Comparative effectiveness of sodium-glucose co-transporter 2 inhibitors for controlling hyperglycaemia in patients with type 2 diabetes: protocol for a systematic review and network meta-analysis
por: Chen, Min, et al.
Publicado: (2016)

Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetes
por: Smits, Mark M, et al.
Publicado: (2015)

The Hypoglycaemia-Hyperglycaemia Minimizer System in the Management of Type 1 Diabetes
por: Levy, Brian L, et al.
Publicado: (2016)

Luseogliflozin Additively Enhances the Glucose-Lowering Effect of an Incretin Modulator in a High-Carbohydrate Diet
por: Lee, Gendai
Publicado: (2022)

Therapy in the Early Stage: Incretins
por: Cernea, Simona, et al.
Publicado: (2011)

Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwest China
por: Zhang, Fang, et al.
Publicado: (2018)

Incretin hormones as immunomodulators of atherosclerosis
por: Alonso, Nuria, et al.
Publicado: (2012)

The Origin and Understanding of the Incretin Concept
por: Rehfeld, Jens F.
Publicado: (2018)

Early Recognition of Overweight Hyperglycaemia May Improve Clinical Outcomes in Type 2 Diabetes
por: Chockalingam, Anand, et al.
Publicado: (2023)

Association between use of systemic and inhaled glucocorticoids and changes in brain volume and white matter microstructure: a cross-sectional study using data from the UK Biobank
por: van der Meulen, Merel, et al.
Publicado: (2022)

Applying the RE-AIM framework to the Alberta's Caring for Diabetes Project: a protocol for a comprehensive evaluation of primary care quality improvement interventions
por: Wozniak, Lisa, et al.
Publicado: (2012)

Editorial: Incretin agonists in the treatment of obesity
por: Sun, Xiaodong, et al.
Publicado: (2023)

Metformin initiation and renal impairment: a cohort study in Denmark and the UK
por: Christiansen, Christian Fynbo, et al.
Publicado: (2015)

Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes
por: Holst, Jens J., et al.
Publicado: (2011)

Sex differences in body anthropometry and composition in individuals with and without diabetes in the UK Biobank
por: Peters, Sanne A E, et al.
Publicado: (2016)

Relationship between islet autoantibody status and the clinical characteristics of children and adults with incident type 1 diabetes in a UK cohort
por: Bravis, Vassiliki, et al.
Publicado: (2018)

Comparative cardiovascular morbidity and mortality in patients taking different insulin regimens for type 2 diabetes: a systematic review
por: Price, Hilary I, et al.
Publicado: (2015)

Excess costs of type 2 diabetes and their sociodemographic and clinical determinants: a cross-sectional study using data from the German Health Interview and Examination Survey for Adults (DEGS1)
por: König, Hannah, et al.
Publicado: (2021)

Decreased prevalence of diabetes in marijuana users: cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) III
por: Rajavashisth, Tripathi B, et al.
Publicado: (2012)

Rationale and protocol for the After Diabetes Diagnosis REsearch Support System (ADDRESS): an incident and high risk type 1 diabetes UK cohort study
por: Walkey, Helen C, et al.
Publicado: (2017)

Incretin Effects on β-Cell Function, Replication, and Mass: The human perspective
por: Garber, Alan J.
Publicado: (2011)

Incretin Action in the Pancreas: Potential Promise, Possible Perils, and Pathological Pitfalls
por: Drucker, Daniel J.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_37skfi6rmvedh4dduji3mh20l0